Exploring the sequence identity of cytoplasmic chromatin in senescence
Exploring the sequence identity of cytoplasmic chromatin in senescence
批准号:
10452114
负责人:
Zhixun Dou
金额:
$25.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2024-03-31
关键词:
AddressAgeAgingAutomobile DrivingAutophagocytosisBindingBiochemicalBullaCell AgingCell Cycle ArrestCell NucleusCellsChromatinChronicComputer AnalysisCoupledCytoplasmCytoplasmic OrganelleCytoplasmic VesiclesCytosolDNADNA BindingDNA sequencingDevelopmentDiseaseEpigenetic ProcessExhibitsFormaldehydeGene ExpressionGenesGeneticGenomeGenomic DNAGenomic SegmentGrowth FactorImageImmuneImmunoprecipitationInfectionInflammationInflammatoryInflammatory ResponseKnowledgeLaboratoriesLongevityLysosomesMediatingMembraneMusMutationNatural ImmunityNatureNuclear EnvelopeOutcomePathway interactionsPeptide HydrolasesPharmacologic SubstancePhenotypeProcessResearchSamplingSignal TransductionSourceStimulator of Interferon GenesTissuesagedantimicrobialautocrinebasechemokinecrosslinkcytokinegenetic informationhealthspanhealthy agingmicrobialnext generation sequencingnovel strategiesnovel therapeuticsparacrineprogramsprotein complexrecruitsenescencetrafficking
中文摘要
项目总结
细胞衰老是与炎症反应相关的细胞周期停滞的一种稳定形式。衰老
细胞聚集在老化和患病的组织中,被认为是导致
与大多数(如果不是全部)年龄相关疾病有关的慢性炎症。与这一概念相一致,
基因或药物清除衰老细胞可延长小鼠的寿命和健康时间。
衰老细胞分泌大量促炎细胞因子、趋化因子、生长因子和
蛋白酶,统称为衰老相关分泌表型(SASP)。SASP计划
改变组织微环境,招募免疫细胞,最终导致炎症。我们的小组最近
显示衰老的细胞在胞浆中显示基因组DNA,这被细胞解释为一种“危险”
通过触发先天免疫胞浆DNA感应cGAS-STING通路促进SASP
衰老程序。这些发现已经由几个实验室独立复制,并且
总体而言,cGAS-STING途径被认为是SASP计划的中心机制。
衰老过程中一个尚未解决的主要问题是细胞质基因组DNA的遗传起源。我们的影像
结果表明,胞质dna是由染色质片段经核质传递而来。
通过核膜气泡进入细胞质进行运输。但是基因组的哪些部分是
穿梭到细胞质?这些区域的染色质状况如何?基因组会丢失基因吗?这些
问题需要不偏不倚的排序方法来解决。该应用程序提出了两种新的策略
对衰老细胞的胞质DNA进行测序。首先,我们的目标是鉴定cGAS相关的胞浆DNA。
衰老,通过执行cGAS DNA免疫沉淀。第二,我们的目标是从生物化学上分离出
从衰老细胞的细胞质中提取的DNA。DNA样本将接受下一代测序和
计算分析,以探索染色质标记和基因表达状态。这些结果将允许
美国将直接操纵基因组DNA以查询细胞接受基因组后的功能后果
DNA转运到细胞质。
这项研究将帮助衰老领域了解衰老的关键机制--
相关的炎症,并可能揭示以前未知的知识的遗传变化
衰老和衰老。这项研究有可能促进新的方法来靶向和抑制慢性
促进健康衰老和抑制与年龄相关的疾病的炎症。
英文摘要
PROJECT SUMMARY
Cellular senescence is a stable form of cell cycle arrest associated with inflammatory responses. Senescent
cells accumulate in aged and diseased tissues and are considered as one of the major sources contributing to
chronic inflammation that is implicated in most, if not all, age-associated disorders. Consistent with this notion,
genetic or pharmaceutical clearance of senescent cells extend lifespan and healthspan of mice.
Senescent cells secret a large array of pro-inflammatory cytokines, chemokines, growth factors, and
proteases, collectively referred to as senescence-associated secretory phenotype (SASP). The SASP program
alters tissue microenvironment and recruits immune cells, ultimately leading to inflammation. Our group recently
showed that senescent cells exhibit genomic DNA in the cytosol, which is interpreted by the cells as a “danger
signal” by triggering the innate immunity cytosolic DNA sensing cGAS-STING pathway that promotes the SASP
program of senescence. These findings have been independently reproduced by several laboratories, and
collectively the cGAS-STING pathway is considered as a central mechanism for the SASP program.
A major unaddressed question in senescence is the genetic origin of cytosolic genomic DNA. Our imaging
results suggest that the cytosolic DNA is derived from fragments of chromatin, mediated by nucleus-to-cytoplasm
trafficking, via nuclear membrane blebs that partition into the cytoplasm. But which parts of the genome are
shuttled to the cytoplasm? What is the chromatin status of those regions? Does the genome lose genes? These
questions require unbiased sequencing approaches to address. This application proposes two novel strategies
to sequence cytoplasmic DNA in senescent cells. First, we aim to identify cGAS-associated cytosolic DNA in
senescence, by performing cGAS DNA-immunoprecipitation. Second, we aim to biochemically fractionate the
DNA from the cytoplasm of senescent cells. The DNA samples will be subjected to next-gen sequencing and
computational analyses to explore the chromatin marks and gene expression status. These results will permit
us to directly manipulate the genomic DNA to inquire the functional consequences of cells undergoing genomic
DNA trafficking to the cytoplasm.
This study will help the senescence field understand a critical mechanism underlying senescence-
associated inflammation, and may reveal previously unknown knowledge of the genetic alterations of
senescence and aging. This study has the potential to facilitate new approaches to target and inhibit chronic
inflammation to promote healthy aging and to suppress age-associated diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nucleus-to-cytoplasm trafficking of chromatin fragments in senescence and aging
-
批准号:10722474
-
项目类别:
-
资助金额:$55.71万
-
财政年份:2023
-
负责人:Zhixun Dou
-
依托单位:
Exploring the sequence identity of cytoplasmic chromatin in senescence
-
批准号:10629244
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2022
-
负责人:Zhixun Dou
-
依托单位:
Single-cell proteomic identification of novel markers of senescence
-
批准号:10907052
-
项目类别:
-
资助金额:$90.18万
-
财政年份:2021
-
负责人:Zhixun Dou
-
依托单位:
Single-cell proteomic identification of novel markers of senescence
-
批准号:10376580
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2021
-
负责人:Zhixun Dou
-
依托单位:
Single-cell proteomic identification of novel markers of senescence
-
批准号:10818822
-
项目类别:
-
资助金额:$10.86万
-
财政年份:2021
-
负责人:Zhixun Dou
-
依托单位:
Autophagy degradation of nuclear and chromatin constituents
-
批准号:10026756
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Zhixun Dou
-
依托单位:
Autophagy degradation of nuclear and chromatin constituents
-
批准号:10408753
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Zhixun Dou
-
依托单位:
Autophagy degradation of nuclear and chromatin constituents
-
批准号:10649629
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2020
-
负责人:Zhixun Dou
-
依托单位:
Autophagy-mediated chromatin degeneration in aging and age-related diseases
-
批准号:9791148
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2018
-
负责人:Zhixun Dou
-
依托单位:
Autophagy-mediated chromatin degeneration in aging and age-related diseases
-
批准号:9314111
-
项目类别:
-
资助金额:$11.07万
-
财政年份:2017
-
负责人:Zhixun Dou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: